Literature DB >> 12425555

Lymphocytic colitis: clinical features, treatment, and outcomes.

Darrell S Pardi, Venktesh R Ramnath, Edward V Loftus, William J Tremaine, William J Sandborn.   

Abstract

OBJECTIVE: There are no reports of the clinical features or treatment outcomes in large series of patients with lymphocytic colitis, and it is not known whether treatments that appear to be beneficial in patients with collagenous colitis are also beneficial in lymphocytic colitis. We sought to analyze these issues in our patients with lymphocytic colitis.
METHODS: All patients with biopsy-proven lymphocytic colitis evaluated at our institution between January 1, 1997, and December 31, 1999, were identified. Clinical features on presentation and treatment outcomes were abstracted from the medical records.
RESULTS: A total of 170 patients with lymphocytic colitis were identified (median age 67 yr, 61% female). Diarrhea, bloating, rectal urgency, fecal incontinence, weight loss, concomitant autoimmune disorders, and aspirin or nonsteroidal anti-inflammatory drug use were common. Loperamide, diphenoxylate/atropine, and bismuth subsalicylate were effective therapies and were well tolerated. However, no therapy produced a complete response in more than 40% of patients.
CONCLUSIONS: Lymphocytic colitis typically presents in elderly patients as chronic diarrhea. Nocturnal stools, urgency, and abdominal pain occur frequently, as do weight loss, fecal incontinence, and concomitant autoimmune disorders. Many empiric treatment options are used, but overall response rates are disappointing. Randomized controlled trials are needed to determine the optimum therapeutic approach to these patients.

Entities:  

Mesh:

Year:  2002        PMID: 12425555     DOI: 10.1111/j.1572-0241.2002.07030.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  42 in total

Review 1.  Lymphocytic and collagenous colitis: an overview of so-called microscopic colitis.

Authors:  Runjan Chetty; Dhirendra Govender
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

Review 2.  Current Approach to the Evaluation and Management of Microscopic Colitis.

Authors:  Thomas G Cotter; Darrell S Pardi
Journal:  Curr Gastroenterol Rep       Date:  2017-02

3.  Noninfectious colitides: collagenous colitis, lymphocytic colitis, diversion colitis, and chemically induced colitis.

Authors:  Amy J Thorsen
Journal:  Clin Colon Rectal Surg       Date:  2007-02

Review 4.  Review of the microscopic colitides.

Authors:  Eugene F Yen; Darrell S Pardi
Journal:  Curr Gastroenterol Rep       Date:  2011-10

Review 5.  Interventions for treating lymphocytic colitis.

Authors:  Nilesh Chande; Noor Al Yatama; Tania Bhanji; Tran M Nguyen; John Wd McDonald; John K MacDonald
Journal:  Cochrane Database Syst Rev       Date:  2017-07-13

6.  Single-centre experience with anti-tumour necrosis factor treatment in budesonide-refractory microscopic colitis patients.

Authors:  Niki Daferera; Henrik Hjortswang; Simone Ignatova; Andreas Münch
Journal:  United European Gastroenterol J       Date:  2019-08-20       Impact factor: 4.623

Review 7.  Latent lymphocytic enterocolitis associated with celiac disease manifesting after resection for colon cancer: case report and review of the literature.

Authors:  Vikram Tangri; David K Driman; Nilesh Chande
Journal:  Can J Gastroenterol       Date:  2008-09       Impact factor: 3.522

8.  Prevalence of microscopic colitis in patients with diarrhea of unknown etiology in Turkey.

Authors:  Levent Erdem; Sadik Yildirim; Nihat Akbayir; Banu Yilmaz; Necati Yenice; Orhan-Sami Gultekin; Onder Peker
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

9.  Diabetic diarrhea.

Authors:  Milena Gould; Joseph H Sellin
Journal:  Curr Gastroenterol Rep       Date:  2009-10

10.  Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection--an observation in a small case control study.

Authors:  Hee Sun Kim; Jung Hyun Lim; Hyojin Park; Sang In Lee
Journal:  Yonsei Med J       Date:  2009-12-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.